Guadalupe Hayes-Mota is a biotechnologist, entrepreneur, MIT professor, and public servant whose career bridges the private, public, and nonprofit sectors to advance healthcare access and innovation. Born in Mexico and diagnosed with hemophilia at a young age, he overcame medical and personal challenges to cultivate a lifelong passion for technology, health equity, and access. As founder and CEO of Healr Solutions, Hayes-Mota has pioneered technologies that transform drug production and distribution, impacting patients in 43 countries. He teaches biotechnology, entrepreneurship, and public policy at MIT, and serves as Director of Bioethics at Santa Clara University, where he leads the academic program and teaches applied healthcare ethics. His early contributions to drug delivery research under Professor Robert S. Langer and Moderna’s co-founders earned him election to Sigma Xi. He has led large-scale healthcare initiatives, directing the nation’s largest free healthcare system at UCLA Health and contributing to the development of the Affordable Care Act at the RAND Corporation. In industry, his leadership roles at Biogen, Amgen, and GSK as Chief Supply Chain Officer and Senior Vice President of Manufacturing shaped the distribution and production of medicines for 2.3 billion people across 113 countries. Hayes-Mota’s expertise has been recognized through appointments by the President of the United States to the NIH Cures Acceleration Network Review Board and by the Governor of Massachusetts to the Rare Disease Advisory Council. His service extends to boards including Fenway Health, Sanofi, Save One Life, MIT Alumni Association, MIT LGBTQ+ Alumni Association, Forbes Business Council, Fast Company Impact Council, and the Harvard Business Review Advisory Council. He also serves as an AI Expert Advisor to the European Commission, helping shape global AI policy, and advices OpenAI. Academically, Hayes-Mota holds dual BS degrees in Chemistry and Literature, an MS in AI Engineering Systems, and an MBA from MIT, where he was a Leaders for Global Operations Fellow. He also earned a Master of Public Policy from Georgetown University and a Master of Public Administration from Harvard University, where he was both a Center for Public Leadership Fellow and a John F. Kennedy Fellow. He is currently completing a Doctorate of Engineering in AI and Machine Learning at The George Washington University, focusing on AI applications in drug development. His leadership has earned him recognition as one of the 100 Most Influential and Inspiring Leaders in Life Sciences (PharmaVoice), one of the six most powerful LGBTQ+ leaders on corporate boards (Business Insider), one of the United States’ most innovative engineers (National Academy of Engineering), and Healthcare Executive of the Year (Los Angeles Business Journal).